Safety and tolerability of Panax ginseng root extract: a randomized, placebo-controlled, clinical trial in healthy Korean volunteers
- PMID: 22909282
- PMCID: PMC3501011
- DOI: 10.1089/acm.2011.0591
Safety and tolerability of Panax ginseng root extract: a randomized, placebo-controlled, clinical trial in healthy Korean volunteers
Abstract
Objectives: Panax ginseng has been extensively used as an adaptogen and is among the top 10 selling herbal supplements in the United States over the past decade. However, there have been few reports about the toxicity of P. ginseng in human studies. Given the lack of toxicological studies in human, this study investigated whether P. ginseng administration causes any noticeable toxic effects in healthy volunteers.
Methods: This study was designed as a randomized, double-blind, placebo-controlled, and parallel group trial in healthy volunteers. The subjects were required to be healthy, free from any significant disease, as assessed at screening by physical examination, medical history, and laboratory (hematological and biochemical) tests. Eligible subjects received P. ginseng extract (1 g/day or 2 g/day) or placebo over a 4-week period.
Results: Although mild adverse events, such as dyspepsia, hot flash, insomnia, and constipation, were reported in both P. ginseng and placebo group, no serious untoward reactions were reported following P. ginseng administration. Nonsignificant changes were observed in hematological and biochemical tests.
Conclusions: P. ginseng administration for 4 weeks was shown to be safe, tolerable, and free of any untoward toxic effect in healthy male and female volunteers. Future results from ongoing multicenter collaborative efforts to evaluate short- and long-term effects of P. ginseng may contribute to our current understanding of safety and tolerability of this herbal product.
Figures
Similar articles
-
Effects of Korean Red Ginseng (Panax ginseng C.A. Meyer) on Menopausal Symptoms in Premenopausal Women After Gynecologic Cancer Surgery: A Double-Blind, Randomized Controlled Trial.J Altern Complement Med. 2021 Jan;27(1):66-72. doi: 10.1089/acm.2019.0429. Epub 2020 Nov 20. J Altern Complement Med. 2021. PMID: 33216632 Clinical Trial.
-
Modulation of endothelial function by Korean red ginseng (Panax ginseng C.A. Meyer) and its components in healthy individuals: a randomized controlled trial.Cardiovasc Ther. 2014 Aug;32(4):163-9. doi: 10.1111/1755-5922.12077. Cardiovasc Ther. 2014. PMID: 24758417 Clinical Trial.
-
KGR-BG1, a Standardized Korean Black Ginseng Extract, Has No Significant Effects on Head or Face Temperature Compared with Korean Red Ginseng Extract and a Placebo.J Med Food. 2022 Jun;25(6):636-644. doi: 10.1089/jmf.2022.K.0007. J Med Food. 2022. PMID: 35708631 Clinical Trial.
-
Ginseng for cognition.Cochrane Database Syst Rev. 2010 Dec 8;(12):CD007769. doi: 10.1002/14651858.CD007769.pub2. Cochrane Database Syst Rev. 2010. PMID: 21154383 Review.
-
Menopause: a review of botanical dietary supplements.Am J Med. 2005 Dec 19;118 Suppl 12B:98-108. doi: 10.1016/j.amjmed.2005.09.044. Am J Med. 2005. PMID: 16414334 Review.
Cited by
-
Preparation, optimization, and characterization of genistein-ginseng long-acting polymeric gel as a breast cancer treatment alternative.Discov Oncol. 2024 Jul 3;15(1):257. doi: 10.1007/s12672-024-01132-8. Discov Oncol. 2024. PMID: 38960937 Free PMC article.
-
The Search for Drugs Derived from Natural Products for Toxoplasma gondii Infection Treatment in the Last 20 Years - A Systematic Review.Curr Top Med Chem. 2024;24(22):1960-1999. doi: 10.2174/0115680266299409240606062235. Curr Top Med Chem. 2024. PMID: 38952156
-
The Effect of Ginseng Supplementation on Lipid Profile: GRADE-assessed Systematic Review and Dose-response Meta-analysis of Randomized Controlled Trials.Curr Pharm Des. 2024;30(26):2047-2058. doi: 10.2174/0113816128306300240522074056. Curr Pharm Des. 2024. PMID: 38877862
-
Phytochemicals Target Multiple Metabolic Pathways in Cancer.Antioxidants (Basel). 2023 Nov 17;12(11):2012. doi: 10.3390/antiox12112012. Antioxidants (Basel). 2023. PMID: 38001865 Free PMC article. Review.
-
Ginsenosides: changing the basic hallmarks of cancer cells to achieve the purpose of treating breast cancer.Chin Med. 2023 Sep 25;18(1):125. doi: 10.1186/s13020-023-00822-9. Chin Med. 2023. PMID: 37749560 Free PMC article. Review.
References
-
- Radad K. Gille G. Liu L. Rausch WD. Use of ginseng in medicine with emphasis on neurodegenerative disorders. J Pharmacol Sci. 2006;100:175–186. - PubMed
-
- Duke J. The Green Pharmacy Herbal Handbook: Your Comprehensive Reference to the Best Herbs for Healing. Emmaus, PA: Rodale; 2000.
-
- Blumenthal M. The ABC Clinical Guide to Herbs. New York: Thieme; 2003.
-
- Blumenthal M. Cavaliere C. Rea P. Herbal supplement sales in United States show growth in all channels. HerbalGram. 2008;78:60–63.
-
- Yi SW. Sull JW. Hong JS, et al. Association between ginseng intake and mortality: Kangwha cohort study. J Altern Complement Med. 2009;15:921–928. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous